Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiayang Lin

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of the American Heart Association|August 15, 2023
Associations of Oral Contraceptive Use With Cardiovascular Disease and All-Cause Death: Evidence From the UK Biobank Cohort StudyWeijuan Dou, Yan Huang, Xuesong Liu, et al.
The Journal of Biological Chemistry|April 21, 2022
Leukemia inhibitory factor protects against liver steatosis in nonalcoholic fatty liver disease patients and obese miceYouwen Yuan, Kangli Li, Fei Teng, et al.
JAMA Network Open|March 17, 2023
Effects of Time-Restricted Eating on Nonalcoholic Fatty Liver Disease: The TREATY-FLD Randomized Clinical TrialXueyun Wei, Bingquan Lin, Yan Huang, et al.
The Journal of Clinical Endocrinology and Metabolism|September 4, 2023
Associations of Serum Testosterone and Sex Hormone-binding Globulin With Incident Arrhythmias in Men From UK BiobankBingyan Xu, Wei Mo, Xiangliang Tan, et al.
BMJ (Clinical Research Ed.)|January 22, 2025
Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trialYuejun Liu, Ying Chen, Jianhua Ma, et al.
Cell Metabolism|October 17, 2024
SGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8<sup>+</sup> T cell activationWenhui Liu, Danming You, Jiayang Lin, et al.
Cell Metabolism|September 7, 2024
SGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8<sup>+</sup> T cell activationWenhui Liu, Danming You, Jiayang Lin, et al.
BMJ (Clinical Research Ed.)|June 4, 2025
Effect of dapagliflozin on metabolic dysfunction-associated steatohepatitis: multicentre, double blind, randomised, placebo controlled trialJiayang Lin, Yan Huang, Bingyan Xu, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of the American Heart Association|August 15, 2023
Associations of Oral Contraceptive Use With Cardiovascular Disease and All-Cause Death: Evidence From the UK Biobank Cohort StudyWeijuan Dou, Yan Huang, Xuesong Liu, et al.
The Journal of Biological Chemistry|April 21, 2022
Leukemia inhibitory factor protects against liver steatosis in nonalcoholic fatty liver disease patients and obese miceYouwen Yuan, Kangli Li, Fei Teng, et al.
JAMA Network Open|March 17, 2023
Effects of Time-Restricted Eating on Nonalcoholic Fatty Liver Disease: The TREATY-FLD Randomized Clinical TrialXueyun Wei, Bingquan Lin, Yan Huang, et al.
The Journal of Clinical Endocrinology and Metabolism|September 4, 2023
Associations of Serum Testosterone and Sex Hormone-binding Globulin With Incident Arrhythmias in Men From UK BiobankBingyan Xu, Wei Mo, Xiangliang Tan, et al.
BMJ (Clinical Research Ed.)|January 22, 2025
Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trialYuejun Liu, Ying Chen, Jianhua Ma, et al.
Cell Metabolism|October 17, 2024
SGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8<sup>+</sup> T cell activationWenhui Liu, Danming You, Jiayang Lin, et al.
Cell Metabolism|September 7, 2024
SGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8<sup>+</sup> T cell activationWenhui Liu, Danming You, Jiayang Lin, et al.
BMJ (Clinical Research Ed.)|June 4, 2025
Effect of dapagliflozin on metabolic dysfunction-associated steatohepatitis: multicentre, double blind, randomised, placebo controlled trialJiayang Lin, Yan Huang, Bingyan Xu, et al.
Pageof 3